We hereby submit Earnings Call Transcript Q1FY27.
AI summary
- Q1FY27 revenue reached INR3,927 million, up 51% y-y; EBITDA INR917 million, PAT INR454 million
- New hospitals contributed 27% of revenue; Faridabad Sector 20 hospital breakeven in 9 months
- Group ARPOB rose 7% y-y to INR34,758; premium hospitals crossed INR50,000 ARPOB
- EBITDA margin adjusted for new hospitals at 28.1%; group targets 24-25% EBITDA margin for FY27
- Capacity at 2,555 beds; target 5,000 beds within ~2.5 years, including Gurugram opening Q1FY28
- New hospitals expected to reach 15-20% EBITDA margin within 15 months post breakeven
- Capex per bed rising to INR75-80 lakhs due to equipment and real estate costs
- Payer mix: government ~40%, newer hospitals <10%; focus on cash/private insurance
- ARPOB growth guidance 8-10% y-y; revenue growth and margins expected to surpass FY26 levels
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 YATHARTH — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add YATHARTH to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Yatharth Hospital & Trauma Care Services Limited
Important.
The summary above is generated automatically from Yatharth Hospital & Trauma Care Services Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.